152 related articles for article (PubMed ID: 35722423)
1. Methyltransferase SETD2 mediates hepatoprotection of berberine against steatosis.
Dai L; Lu S; Shen T; Li Y; Chen J
Ann Transl Med; 2022 May; 10(10):552. PubMed ID: 35722423
[TBL] [Abstract][Full Text] [Related]
2. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
3. Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis.
Shan MY; Dai Y; Ren XD; Zheng J; Zhang KB; Chen B; Yan J; Xu ZH
J Integr Med; 2021 Nov; 19(6):545-554. PubMed ID: 34686466
[TBL] [Abstract][Full Text] [Related]
4. The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3).
Berthelet J; Michail C; Bui LC; Le Coadou L; Sirri V; Wang L; Dulphy N; Dupret JM; Chomienne C; Guidez F; Rodrigues-Lima F
Mol Pharmacol; 2021 Sep; 100(3):283-294. PubMed ID: 34266924
[TBL] [Abstract][Full Text] [Related]
5. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of Histone Methyltransferase SET Domain-Containing 2 in Liver Leads to Abnormal Lipid Metabolism and HCC.
Li XJ; Li QL; Ju LG; Zhao C; Zhao LS; Du JW; Wang Y; Zheng L; Song BL; Li LY; Li L; Wu M
Hepatology; 2021 May; 73(5):1797-1815. PubMed ID: 33058300
[TBL] [Abstract][Full Text] [Related]
7. Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma.
Yu M; Qian K; Wang G; Xiao Y; Zhu Y; Ju L
Front Oncol; 2023; 13():1114461. PubMed ID: 37025591
[TBL] [Abstract][Full Text] [Related]
8. Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice.
Xue M; Zhang L; Yang MX; Zhang W; Li XM; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
Int J Nanomedicine; 2015; 10():5049-57. PubMed ID: 26346310
[TBL] [Abstract][Full Text] [Related]
9. Berberine attenuates hepatic oxidative stress in rats with non-alcoholic fatty liver disease via the Nrf2/ARE signalling pathway.
Deng Y; Tang K; Chen R; Nie H; Liang S; Zhang J; Zhang Y; Yang Q
Exp Ther Med; 2019 Mar; 17(3):2091-2098. PubMed ID: 30867696
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of the histone methyltransferase SETD2 promotes imatinib resistance in chronic myeloid leukaemia cells.
Sheng Y; Ji Z; Zhao H; Wang J; Cheng C; Xu W; Wang X; He Y; Liu K; Li L; Voeltzel T; Maguer-Satta V; Gao WQ; Zhu HH
Cell Prolif; 2019 Jul; 52(4):e12611. PubMed ID: 31054182
[TBL] [Abstract][Full Text] [Related]
11. Microarray Expression Profiling and Raman Spectroscopy Reveal Anti-Fatty Liver Action of Berberine in a Diet-Induced Larval Zebrafish Model.
Chen B; Zheng YM; Zhang MQ; Han Y; Zhang JP; Hu CQ
Front Pharmacol; 2019; 10():1504. PubMed ID: 31969822
[No Abstract] [Full Text] [Related]
12. Berberine attenuates atherosclerotic lesions and hepatic steatosis in ApoE
Ma CY; Shi XY; Wu YR; Zhang Y; Yao YH; Qu HL; Zhang W; Guo YL; Xu RX; Li JJ
Ann Transl Med; 2021 Oct; 9(20):1517. PubMed ID: 34790723
[TBL] [Abstract][Full Text] [Related]
13. H3K36 trimethylation mediated by SETD2 regulates the fate of bone marrow mesenchymal stem cells.
Wang L; Niu N; Li L; Shao R; Ouyang H; Zou W
PLoS Biol; 2018 Nov; 16(11):e2006522. PubMed ID: 30422989
[TBL] [Abstract][Full Text] [Related]
14. Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity.
Guo T; Woo SL; Guo X; Li H; Zheng J; Botchlett R; Liu M; Pei Y; Xu H; Cai Y; Zeng T; Chen L; Li X; Li Q; Xiao X; Huo Y; Wu C
Sci Rep; 2016 Mar; 6():22612. PubMed ID: 26936230
[TBL] [Abstract][Full Text] [Related]
15. The histone methyltransferase SETD2 is required for expression of acrosin-binding protein 1 and protamines and essential for spermiogenesis in mice.
Zuo X; Rong B; Li L; Lv R; Lan F; Tong MH
J Biol Chem; 2018 Jun; 293(24):9188-9197. PubMed ID: 29716999
[TBL] [Abstract][Full Text] [Related]
16. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.
Xu X; Zhu XP; Bai JY; Xia P; Li Y; Lu Y; Li XY; Gao X
FASEB J; 2019 Jun; 33(6):7289-7300. PubMed ID: 30848932
[TBL] [Abstract][Full Text] [Related]
17. Paternal high-fat diet altered H3K36me3 pattern of pre-implantation embryos.
Meng B; He J; Cao W; Zhang Y; Qi J; Luo S; Shen C; Zhao J; Xue Y; Qu P; Liu E
Zygote; 2024 Feb; 32(1):1-6. PubMed ID: 38018398
[TBL] [Abstract][Full Text] [Related]
18. Effects of berberine and cinnamic acid on palmitic acid-induced intracellular triglyceride accumulation in NIT-1 pancreatic β cells.
Zhao L; Jiang SJ; Lu FE; Xu LJ; Zou X; Wang KF; Dong H
Chin J Integr Med; 2016 Jul; 22(7):496-502. PubMed ID: 25491540
[TBL] [Abstract][Full Text] [Related]
19. Histone Methyltransferase SETD2 Is Required for Porcine Early Embryonic Development.
Shao W; Ning W; Liu C; Zou Y; Yao Y; Kang J; Cao Z
Animals (Basel); 2022 Aug; 12(17):. PubMed ID: 36077946
[TBL] [Abstract][Full Text] [Related]
20. Berberine Protects Against Palmitate-Induced Apoptosis in Tubular Epithelial Cells by Promoting Fatty Acid Oxidation.
Sun J; Chen X; Liu T; Jiang X; Wu Y; Yang S; Hua W; Li Z; Huang H; Ruan X; Du X
Med Sci Monit; 2018 Mar; 24():1484-1492. PubMed ID: 29528039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
